Previous close | 576.00 |
Open | 576.00 |
Bid | 585.00 x 0 |
Ask | 588.00 x 0 |
Day's range | 575.00 - 591.00 |
52-week range | 522.00 - 1,567.00 |
Volume | |
Avg. volume | 772,826 |
Market cap | 73.515B |
Beta (5Y monthly) | -0.01 |
PE ratio (TTM) | 13.37 |
EPS (TTM) | 43.91 |
Earnings date | 24 July 2024 - 29 July 2024 |
Forward dividend & yield | 20.00 (3.41%) |
Ex-dividend date | 27 Sept 2024 |
1y target est | 1,082.90 |
HYOGO, Japan, March 19, 2024--JCR Pharmaceuticals announces achievement of milestone using J-Brain Cargo® for neurodegenerative disease in research collaboration with Alexion.
HYOGO, Japan, February 29, 2024--JCR Pharmaceuticals celebrates Rare Disease Day 2024 and highlights its commitment to the rare disease community.
HYOGO, Japan, February 14, 2024--JCR announced the presentation of several datasets demonstrating the potential benefits of its investigational LSD therapies at the WORLDSymposium™.